French to modify breast implant ban soon?
This article was originally published in Clinica
A decree relaxing the French ban on the sale and implantation of all non-saline breast prostheses could be published before the current ruling expires in May. Under present legislation, these products may only be sold once they have French premarket approval (homologation) through a type-testing procedure involving risk assessment. A spokesman for the Health Ministry explained to Clinica that the Ministries involved in drawing up the decree - Health and Economic Affairs - have come to an agreement that a new text should be published which would accept CE-marked breast implants on certain conditions.
You may also be interested in...
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.
C&D CEO Matthew Farrell says Zicam has 73% share in the US zinc-containing wellness product market. It's acquiring marketer Matrixx Initiatives at a price almost 15 times Zicam brand’s projected 2021 EBITDA.